Publication Cover
Mycology
An International Journal on Fungal Biology
Volume 10, 2019 - Issue 2
2,247
Views
20
CrossRef citations to date
0
Altmetric
Articles

Antifungal-resistant Mucorales in different indoor environments

ORCID Icon, , , &
Pages 75-83 | Received 30 Jul 2018, Accepted 17 Nov 2018, Published online: 26 Nov 2018

References

  • Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. 2007. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother. 51(7):2587–2590.
  • Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, Nachbaur D. 2012. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother. 67:2268–2273.
  • Bergwall C, Stehn B. 2002. Comparison of selective mycological agar media for the isolation and enumeration of xerophilic moulds and osmotolerant yeasts in granulated white sugar Zuckerindustrie. Sugar Ind. 127(4):259–264.
  • Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, Desenclos JC, Lortholary O. 2009. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 15:1395–1401.
  • Caetano LA, Faria T, Crespo Batista A, Viegas S, Viegas C. 2017. Assessment of occupational exposure to azole resistant fungi in 10 Portuguese bakeries. AIMS Microbiol. 3(4):960–975.
  • Caetano LA, Zegre M, Viegas C. 2018. Azole resistance screening in occupational exposure assessments to mycobiota. In: Arezes, editor. Occupational safety and hygiene VI. London: Taylor & Francis; p. 61–64.
  • Caramalho R, Tyndall JDA, Monk BC, Larentis T, Lass-Flörl C, Lackner M. 2017. Intrinsic short-tailed azole resistance in mucormycetes is due to an evolutionary conserved aminoacid substitution of the lanosterol 14α-demethylase. Sci Rep. 7(1):15898.
  • Chowdhary A, Kathuria S, Singh PK, Sharma B, Dolatabadi S, Hagen F, Meis JF. 2014. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses. 57(3):97–107.
  • Cuenca-Estrella M. 2014. Antifungal drug resistance mechanisms in pathogenic fungi: from bench to bedside. Clin Microbiol Infect. 20(6):54–59.
  • Dannaoui E. 2017. Antifungal resistance in mucorales. Int J Antimicrob Agents. 50(5):617–621.
  • Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother. 51(1):45–52.
  • De Hoog GS, Guarro J, Gene J, Figueras MJ. 2000. Atlas of clinical fungi. Utrecht: Centraalbureau voor Schimmelcultures.
  • Espinel-Ingroff A, Chakrabarti A, Chowdhary A, Cordoba S, Dannaoui E, Dufresne P, Fothergill A, Ghannoum M, Gonzalez GM, Guarro J, et al. 2015. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother. 59(3):1745–1750.
  • The European Committee on Antimicrobial Susceptibility Testing, Breakpoint tables for interpretation of MICs and zone diameters, version 7.1. 2017. http://www.eucast.org.
  • Fairlamb AH, Gow NA, Matthews KR, Waters AP. 2016. Drug resistance in eukaryotic microorganisms. Nat Microbiol. 1(7):16092.
  • Hyvärinen A, Vahteristo M, Meklin T, Jantunen M, Nevalainen A, Moschandreas D. 2001. Temporal and spatial variation of fungal concentrations in indoor air. Aerosol Sci Technol. 35(2):688–695.
  • Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA. 2004. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis. 39(5):743–746.
  • Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, et al. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus- active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 191(8):1350–1360.
  • Kwon-Chung KJ. 2012. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 54(1):S8–S15.
  • Lackner M, Caramalho R, Lass-Flörl C. 2014. Laboratory diagnosis of mucormycosis: current status and future perspectives. Future Microbiol. 9(5):683–695.
  • Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O. 2012. A global analysis of mucormycosis in France: the RetroZygo study (2005–2007). Clin Infect Dis. 54(1):S35–S43.
  • Lauriere M, Gorner P, Bouchezmahiout I, Wrobel R, Breton C, Fabrie JF, Choudat D. 2008. Physical and biochemical properties of airborne flour particles involved in occupational asthma. Ann Occup Hyg. 52(8):727–737.
  • Lavergne RA, Chouaki T, Hagen F, Toublanc B, Dupont H, Jounieaux V, Meis JF, Morio F, Le Pape P. 2017. Home environment as a source of life-threatening azole-resistant Aspergillus fumigatus in immunocompromised patients. Clin Infect Dis. 64(1):76–78.
  • Leathers TD, Sypherd PS. 1985. Inducible phenotypic multidrug resistance in the fungus Mucor racemosus. Antimicrob Agents Chemother. 27(6):892–896.
  • Leppänen HK, Täubel M, Jayaprakash B, Vepsäläinen A, Pasanen P, Hyvärinen A. 2018. Quantitative assessment of microbes from samples of indoor air and dust. J Expo Sci Environ Epidemiol. 28(3):231–241.
  • Millon L, Larosa F, Lepiller Q, Legrand F, Rocchi S, Daguindau E, Scherer E, Bellanger AP, Leroy J, Grenouillet F. 2013. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis. 56:e95–e101.
  • Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 54(1):S23–S34.
  • Sabino R, Veríssimo C, Brandão J, Martins C, Alves D, Pais C, Denning DW. 2017. Serious fungal infections in Portugal. Eur J Clin Microbiol Infect Dis. 36(7):1345–1352.
  • Springer J, Goldenberger D, Schmidt F, Weisser M, Wehrle-Wieland E, Einsele H, Frei R, Löffler J. 2016a. Development and application of two independent real-time PCR assays to detect clinically relevant mucorales species. J Med Microbiol. 65:227–234.
  • Springer J, Lackner M, Ensinger C, Risslegger B, Morton CO, Nachbaur D, Lass-Flörl C, Einsele H, Heinz WJ, Loeffler J. 2016b. Clinical evaluation of Mucorales-specific real-time PCR assay in tissue and serum samples. J Med Microbiol. 65(12):1414–1421.
  • Editorial. 2017. Stop neglecting fungi. Nat Microbiol. 2:17120. DOI: 10.1038/nmicrobiol.2017.120.
  • Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. 2002. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother. 46(5):1581–1582.
  • Viegas C, Carolino E, Sabino R, Viegas S, Veríssimo C. 2013. Fungal contamination in swine: a potential occupational health threat. J Toxicol Environ Heal Part A. 76:272–280.
  • Viegas C, Faria T, Caetano LA, Carolino E, Quintal Gomes A, Viegas S. 2017a. Aspergillus spp. prevalence in different occupational environments: what is the real scenario in high load settings? J Occup Environ Hyg. 14(10):771–785.
  • Viegas C, Faria T, Caetano LA, Loeffler J, Springer J. 2018a. Mucorales prevalence and azole-resistance surveillance on different indoor environments: a menace to be tackled. In: 8th Advances Against Aspergillosis. Lisbon; p. 19. 87.
  • Viegas C, Faria T, Carolino E, Sabino R, Gomes AQ, Viegas S. 2016a. Occupational exposure to fungi and particles in animal feed industry. Med Pr. 67(2):143–154.
  • Viegas C, Faria T, de Oliveira AC, Caetano LA, Carolino E, Quintal-Gomes A, Twarużek M, Kosicki R, Soszczyńska E, Viegas S. 2017b. A new approach to assess occupational exposure to airborne fungal contamination and mycotoxins of forklift drivers in waste sorting facilities. Mycotoxin Res. 33(4):285–295.
  • Viegas C, Faria T, Dos Santos M, Carolino E, Gomes AQ, Sabino R, Viegas S. 2015. Fungal burden in waste industry: an occupational risk to be solved. Environ Monit Assess. 187(4):199.
  • Viegas C, Faria T, Dos Santos M, Carolino E, Sabino R, Gomes AQ, Viegas S. 2016b. Slaughterhouses fungal burden assessment: a contribution for the pursuit of a better assessment strategy. Int J Environ Res Public Health. 13:1–11.
  • Viegas C, Faria T, Monteiro A, Caetano LA, Carolino E, Gomes AQ, Viegas S. 2018b. A novel multi-approach protocol for the characterization of occupational exposure to organic dust-Swine production case study. Toxics. 6(1):E5.
  • Viegas C, Gomes AQ, Abegão J, Sabino R, Graça T, Viegas S. 2014. Assessment of fungal contamination in waste sorting and incineration—case study in Portugal. J Toxicol Environ Heal Part A. 77(1–3):57–68.
  • Viegas C, Monteiro A, Caetano LA, Faria T, Carolino E, Viegas S. 2018c. Electrostatic dust cloth: a passive screening method to assess occupational exposure to organic dust in bakeries. Atmosphere (Basel). 9(2):64.
  • Viegas C, Monteiro A, Dos Santos M, Faria T, Caetano LA, Carolino E, Quintal-Gomes A, Marchand G, Lacombe N, Viegas S. 2018d. Filters from taxis air conditioning system: a tool to characterize driver’s occupational exposure to bioburden? Environ Res. 164:522–529.
  • Vitale RG, de Hoog GS, Schwarz P, Dannaoui E, Deng S, Machouart M, Voigt K, van de Sande WW, Dolatabadi S, Meis JF, et al. 2012. Antifungal susceptibility and phylogeny of opportunistic members of the order Mucorales. J Clin Microbiol. 50(1):66–75.